OPKO Health
OPK
#5845
Rank
HK$9.13 B
Marketcap
HK$12.31
Share price
-2.48%
Change (1 day)
20.70%
Change (1 year)

P/S ratio for OPKO Health (OPK)

P/S ratio as of November 2026 (TTM): 2.35

According to OPKO Health 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.9970. At the end of 2026 the company had a P/S ratio of 2.32.

P/S ratio history for OPKO Health from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20262.3217.79%
20251.9741.12%
20241.403.29%
20231.3540.55%
20220.9618-47.91%
20211.850.16%
20201.8468.88%
20191.09-38.74%
20181.78-35.06%
20172.74-35.33%
20164.24-61.9%
201511.1-76.49%
201447.431.35%
201336.115.46%
201231.2-38.54%
201150.889.59%
201026.8-24.09%
200935.33.57%
200834.1
200358.6824.51%
20026.34-84.32%
200140.4

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.59 180.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.83 62.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.67 141.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.42 2.67%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
2.05-12.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
3.95 68.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.70 14.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Ardelyx
ARDX
1.61-31.45%๐Ÿ‡บ๐Ÿ‡ธ USA